60 related articles for article (PubMed ID: 9244658)
1. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[TBL] [Abstract][Full Text] [Related]
2. A randomised control trial on sequential drug monotherapy versus conventional step care therapy in the treatment of mild to moderate hypertension.
Jagadevan R; Cherian AM; Jeyaseelan L; Peter JV
J Assoc Physicians India; 1999 Feb; 47(2):173-6. PubMed ID: 10999082
[TBL] [Abstract][Full Text] [Related]
3. [Basic principles and possible variations in combination antihypertensive therapy].
Scholze J
Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):155-63. PubMed ID: 9244658
[TBL] [Abstract][Full Text] [Related]
4. Combination versus Monotherapy as Initial Treatment in Hypertension.
Holzgreve H
Herz; 2003 Dec; 28(8):725-32. PubMed ID: 14689107
[TBL] [Abstract][Full Text] [Related]
5. [Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy].
González Maqueda I; Gómez Guindal JA; González Lama I
Rev Esp Cardiol; 1999; 52 Suppl 3():59-72. PubMed ID: 10614151
[TBL] [Abstract][Full Text] [Related]
6. [Refractory hypertension--principles of combination therapy].
Hitzenberger G
Acta Med Austriaca; 1995; 22(3):43-5. PubMed ID: 8571749
[TBL] [Abstract][Full Text] [Related]
7. Healthcare benefits of very-low-dose combination treatment used in the management of hypertension.
Ambrosioni E
J Hypertens Suppl; 2001 Nov; 19(4):S29-36. PubMed ID: 11848260
[TBL] [Abstract][Full Text] [Related]
8. [Initial combination treatment of hypertension].
Düsing R
MMW Fortschr Med; 2004 Nov; 146(47):46-8. PubMed ID: 15624658
[TBL] [Abstract][Full Text] [Related]
9. Rationale for the use of very-low-dose combinations as first-line treatment of hypertension.
Waeber B; Brunner HR
J Hypertens Suppl; 2001 Nov; 19(4):S3-8. PubMed ID: 11848261
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
